Details for 2016744237

Up to date per 04.04.2026

Actions

Title / Product Name

7-BENZYL-4-(4-(TRIFLUOROMETHYL)BENZYL)-1,2,6,7,8,9-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[3,4-E]PYRIMIDIN-5(4H)-ON UND SALZE DAVON UND DEREN VERWENDUNG IN DER THERAPIE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016744237

EP Publication Number

3250208

E-Number

1318078

Language

PCT Number

US16015817

Publication Date

06.12.2017 A

30.09.2020 B1

Registration Date

30.09.2020

AT Publication Date

15.10.2020

Application Date

29.01.2016

Registration Number

Priorities

30.01.2015

201562109737 P

17.04.2015

201562148844 P

28.09.2015

201562233757 P

IPC

A61K 31/519 20060101AFI20180827BHEP

Maximum Duration of Protection

29.01.2036

Owner

Oncoceutics, Inc.3675 Market Street Suite 200 Philadelphia, PA 19104US

Representative

Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT

Inventor

STOGNIEW, Martin7811 Mathern Ct. Lakewood Ranch, Florida 34202US

ALLEN, Joshua E.43 Chestnut St., Unit 311 New Haven, Connecticut 06511US

POTTORF, Richard S.7550 Prairie View Dr. Indianapolis, Indiana 46526US

NALLAGANCHU, Bhaskara Rao99 Nostrand Road Hillsborough, New Jersey 08852US

OLSON, Gary L.1505 Coles Avenue Mountainside, New Jersey 07092US

SUN, Yanjun14 Greyhound Court Kendall Park, New Jersey 08824US

Information about Fees